Cognition Therapeutics, Inc. Profile Avatar - Palmy Investing

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead…

Biotechnology
US, Purchase [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of CGTX's Analysis
CIK: 1455365 CUSIP: 19243B102 ISIN: US19243B1026 LEI: - UEI: -
Secondary Listings
CGTX has no secondary listings inside our databases.